[Risk factors for coronary heart disease in 1002 patients with hyperlipidemia]

L Kłosiewicz-Latoszek1, L Pachocka, K Górska

  • 1Instytutu Zywności i Zywienia, Warszawa.

Insights

Most hyperlipidemic patients (over 83%) have multiple coexisting coronary heart disease (CHD) risk factors. These combined factors significantly elevate CHD risk, necessitating aggressive management strategies for hyperlipidemia and associated conditions.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Hyperlipidemia is a primary risk factor for coronary heart disease (CHD).
  • Understanding the coexistence of multiple risk factors in hyperlipidemic patients is crucial for effective CHD prevention.
  • Prevalence of various cardiovascular risk factors in a hyperlipidemic outpatient population requires investigation.

Purpose of the Study:

  • To estimate the prevalence and coexistence of major risk factors for coronary heart disease (CHD) in patients with hyperlipidemia.
  • To identify specific risk factor profiles associated with a history of myocardial infarction (MI) in this cohort.
  • To emphasize the need for intensive management of multiple risk factors in hyperlipidemic individuals.

Main Methods:

  • Cross-sectional study of 1002 hyperlipidemic patients (601 women, 401 men) over 12 months.
  • Data collection included lipid profiles, body mass index (BMI), blood pressure, diabetes status, smoking history, and family history of cardiovascular disease.
  • Analysis of prevalence for hypercholesterolemia, mixed hyperlipidemia, hypertriglyceridemia, overweight/obesity, hypertension, diabetes mellitus, smoking, familial hyperlipidemia, low HDL cholesterol, and elevated Lp(a).

Main Results:

  • Hypercholesterolemia (66%) and mixed hyperlipidemia (31.8%) were the most common lipid disorders.
  • High prevalence of overweight/obesity (66%), hypertension (37.5%), and diabetes mellitus (11.2%) was observed.
  • Over 83% of patients exhibited multiple coexisting CHD risk factors; those with prior MI showed higher apo B, Lp(a), and lower HDL cholesterol levels.

Conclusions:

  • The vast majority of hyperlipidemic patients present with multiple CHD risk factors.
  • Coexisting risk factors significantly increase the risk of CHD and myocardial infarction.
  • Intensive management strategies targeting multiple risk factors are essential for reducing cardiovascular risk in hyperlipidemic populations.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...